期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Cancer Prevention Research LetPub Score 7.5
50 ratings
Rate
Reputation 8.8 Influence 6.1 Speed 9.4 | ||||||||||||||||||||
期刊簡稱 | CANCER PREV RES | ||||||||||||||||||||
ISSN | 1940-6207 | ||||||||||||||||||||
E-ISSN | 1940-6215 | ||||||||||||||||||||
h-index | 80 | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 3.40%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://cancerpreventionresearch.aacrjournals.org/ | ||||||||||||||||||||
在線稿件提交 | http://capr.msubmit.net/cgi-bin/main.plex | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | American Association for Cancer Research Inc. | ||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | 月刊 | ||||||||||||||||||||
創刊年 | 2008 | ||||||||||||||||||||
每年文章數 | 71每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 15.50% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1940-6207%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Sort of slow, 4-8 Week(s) | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Cancer Prevention Research] 的評論 | 撰寫評論 |
作者: 重阳庆庆 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-08-07 13:11:11 評論於 How is your progress now? How long has it been under review?(0) 讚! | 重阳庆庆 |
作者: 北海玉军 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-03-20 11:16:02 評論於 Under review on the same day, hopefully I can pass(0) 讚! | 北海玉军 |
作者: 风啸友安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-27 08:28:21 評論於 I need to be available at all times(0) 讚! | 风啸友安 |
作者: 寂灭恒鑫 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-08 22:50:31 評論於 Do you need the original data for this?(0) 讚! | 寂灭恒鑫 |
作者: 风啸友安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-31 08:30:59 評論於 The review speed is relatively fast, and the feedback is quite objective. It took about 5 months to complete this article(0) 讚! | 风啸友安 |
作者: 风啸友安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-10-28 23:54:16 評論於 Review speed: 6.0 | Submission hit rate: 50.0 Experience sharing: Submitted on June 18, 2022 Sent for external review on June 21, 2022 First review comments on July 21, 2022 First revision on September 8, 2022 External review on September 14, 2022 Minor revisions + preliminary acceptance on October 6, 2022 Second revision on October 11, 2022 External review on October 21, 2022 Officially accepted on October 21, 2022 Editor is very friendly Page fee = Base fee 900 + Figure 250*6 + Open publication fee 2300 = $4700 USD, if you do not want to publish openly, you can save $2300(0) 讚! | 风啸友安 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 23:35:44 評論於 By summarizing the research subject, materials sources, methods, and techniques used, the reader can understand how this study was conducted. Therefore, the abstract must describe the methods used(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 15:43:11 評論於 Differences between HIGHLIGHTS and abstracts: composed of several key words, not necessarily complete sentences; more concise and shorter in length; HIGHLIGHTS only contain important findings, while abstracts include research objectives and research methods(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 八坂篷蔚 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 11:25:13 評論於 What is the difference between abstract and highlights?(0) 讚! | 八坂篷蔚 |
作者: 平原文波 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:50:52 評論於 Does the abstract need to describe the methods used?(0) 讚! | 平原文波 |
作者: 天山凡霜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-21 16:59:50 評論於 Review speed: 1.0 Experience sharing: The review comments were returned in half a month, very efficient. Although the paper was not accepted in the end, a lot of constructive feedback was provided. Pretty good(0) 讚! | 天山凡霜 |
作者: jo仔 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2020-05-21 08:20:13 評論於 The comments returned in half a month. The efficiency is very fast. Although it was not accepted in the end, the reviewers made a lot of pertinent opinions, which were pretty good. (0) 讚! | jo仔 |
作者: 碧桃逸致 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-05-14 14:54:48 評論於 Review Speed: 1.0 Experience Sharing: Submitted on April 19th, under review on April 21st, and received feedback on May 4th. Although not accepted, received many constructive comments. Fast speed, high efficiency, highly recommended(0) 讚! | 碧桃逸致 |
作者: jo仔 領域: 医学 審稿時間: 1.0 month(s) 結果: 拒稿 撰寫評論 |
2020-05-14 08:21:11 評論於 Submitted on April 19th, under review on April 21st, and review comments returned on May 4th. Although it was not accepted, they raised1 many pertinent opinions. Fast speed, high efficiency, awesome! (0) 讚! | jo仔 |
作者: 郭云桑 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-03 19:45:00 評論於 How long does the first review take?(0) 讚! | 郭云桑 |
作者: 重阳文景 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-04-05 19:45:37 評論於 Doesn't anyone pay attention to this magazine? This magazine is under AACR and is actually very good(0) 讚! | 重阳文景 |
作者: 平原梓云 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-22 17:59:01 評論於 The journal of oncology belongs to a relatively good journal, and the feedback from the reviewers is also very detailed(0) 讚! | 平原梓云 |
作者: Barbee 領域: 医学 審稿時間: 4.0 month(s) 結果: 修改後接受 撰寫評論 |
2019-01-22 15:57:45 評論於 The oncology journal is still quite good.The journals and reviewers gave me very detailed comments.(0) 讚! | Barbee |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2015-01-17 11:47:54 評論於 Submitted an article on Chinese herbal medicine anti-tumor and quickly accepted! No additional experiments were required(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-02-24 16:31:07 評論於 (0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us